Clinical Trial Update: Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the combination of durvalumab and tremelimumab after radioembolization for unresectable locally advanced hepatocellular carcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Durvalumab (durvalumab)
• Tremelimumab (tremelimumab)

Snippet

Sponsor: City of Hope Medical Center | Conditions: BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING